Christy Sandborg

Publications

• An i2b2-based, generalizable, open source, self-scaling chronic disease registry. Natter MD, Quan J, Ortiz DM, Bousvaros A, Ilowite NT, Inman CJ, Marsolo K, McMurry AJ, Sandborg CI, Schanberg LE, Wallace CA, Warren RW, Weber GM, Mandl KD. J Am Med Inform Assoc. 2013; 20 (1): 172-9
• Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ardoin SP, Schanberg LE, Sandborg CI, Barnhart HX, Evans GW, Yow E, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, Levy D, von Scheven E, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy DK, Klein-Gitelman M, Wallace C, Silver RM, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed AM, Thompson SD. Ann Rheum Dis. 2013
• Shrinking lung syndrome as a manifestation of pleuritis: a new model based on pulmonary physiological studies. Henderson LA, Loring SH, Gill RR, Liao KP, Ishizawar R, Kim S, Perlmutter-Goldenson R, Rothman D, Son MB, Stoll ML, Zemel LS, Sandborg C, Dellaripa PF, Nigrovic PA. J Rheumatol. 2013; 40 (3): 273-81
• A new era in the treatment of systemic juvenile idiopathic arthritis. Sandborg C, Mellins ED. N Engl J Med. 2012; 367 (25): 2439-40
• Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology. Ilowite NT, Sandborg CI, Feldman BM, Grom A, Schanberg LE, Giannini EH, Wallace CA, Schneider R, Kenney K, Gottlieb B, Hashkes PJ, Imundo L, Kimura Y, Lang B, Miller M, Milojevic D, O'Neil KM, Punaro M, Ruth N, Singer NG, Vehe RK, Verbsky J, Woodward A, Zemel L. Pediatr Rheumatol Online J. 2012; 10 (1): 31
• Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis. Ling XB, Macaubas C, Alexander HC, Wen Q, Chen E, Peng S, Sun Y, Deshpande C, Pan KH, Lin R, Lih CJ, Chang SY, Lee T, Sandborg C, Begovich AB, Cohen SN, Mellins ED. BMC Med. 2012: 10 125
• European ancestry decreases the risk of early onset, severe lupus nephritis in a single center, multiethnic pediatric lupus inception cohort. Frankovich JD, Hsu JJ, Sandborg CI. Lupus. 2012; 21 (4): 421-9
• Reply. Ardoin SP, Evans G, Sandborg C, Barnhart HX, Schanberg LE. Arthritis Rheum. 2012; 64 (8): 2805-2806
• Use of atorvastatin in systemic lupus erythematosus in children and adolescents. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Imundo LF, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro M, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed AM, Provenzale J, Thompson SD. Arthritis Rheum. 2012; 64 (1): 285-96
• Implementing an Interoperable Personal Health Record in Pediatrics: Lessons Learned at an Academic Children's Hospital. Anoshiravani A, Gaskin G, Kopetsky E, Sandborg C, Longhurst CA. J Particip Med. 2011 3
• Behcet's disease and heart transplantation: a word of caution. Hollander SA, Yasnovsky JR, Reinhartz O, Chan F, Sandborg C, Hunt S, Bernstein D, Chin C. J Heart Lung Transplant. 2010; 29 (11): 1306-8
• Decrease in hospital-wide mortality rate after implementation of a commercially sold computerized physician order entry system. Longhurst CA, Parast L, Sandborg CI, Widen E, Sullivan J, Hahn JS, Dawes CG, Sharek PJ. Pediatrics. 2010; 126 (1): 14-21
• Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Ardoin SP, Schanberg LE, Sandborg C, Yow E, Barnhart HX, Mieszkalski Kl, Ilowite NT, von Scheven E, Eberhard A, Levy DM, Kimura Y, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung LK, Imundo L, Soep JB, Reed AM. Lupus. 2010; 19 (11): 1315-25
• Living Profiles: design of a health media platform for teens with special healthcare needs. Chira P, Nugent L, Miller K, Park T, Donahue S, Soni A, Nugent D, Sandborg C. J Biomed Inform. 2010; 43 (5 Suppl): S9-12
• Pediatric rheumatic disease: Standards of care for JIA--the basic foundation for quality. Sandborg C, Nat Rev Rheumatol. 2010; 6 (7): 389-90
• Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Levy DM, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed A. Arthritis Rheum. 2009; 60 (5): 1496-507
• Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, Nemcova D, Mouy R, Sandborg C, Bohnsack J, Elewaut D, Foeldvari I, Gerloni V, Rovensky J, Minden K, Vehe RK, Weiner LW, Horneff G, Huppertz HI, Olson NY, Medich JR, Carcereri-De-Prati R, McIlraith MJ, Giannini EH, Martini A. N Engl J Med. 2008; 359 (8): 810-20
• Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus. Sandborg C, Ardoin SP, Schanberg L. Nat Clin Pract Rheumatol. 2008; 4 (5): 258-65
• Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. Ardoin SP, Sandborg C, Schanberg LE. Lupus. 2007; 16 (8): 618-26
• Availability of pediatric rheumatology training in United States pediatric residencies. Mayer ML, Brogan L, Sandborg CI. Arthritis Rheum. 2006; 55 (6): 836-42
• Candidate early predictors for progression to joint damage in systemic juvenile idiopathic arthritis. Sandborg C, Holmes TH, Lee T, Biederman K, Bloch DA, Emery H, McCurdy D, Mellins ED. J Rheumatol. 2006; 33 (11): 2322-9
• Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. Harel L, Sandborg C, Lee T, von Scheven E. J Rheumatol. 2006; 33 (9): 1873-7
• Rafting the ethical rapids. Collier J, Rorty M, Sandborg C. HEC Forum. 2006; 18 (4): 332-41
• Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). Ward MM, Bruckel J, Colbert R, Doedhar A, Emerson C, Genant H, Gladman DD, Inman R, Reveille JD, Sandborg C, Weisman MH, Davis JC. J Rheumatol. 2006; 33 (5): 978-82
• Systemic hyalinosis: a distinctive early childhood-onset disorder characterized by mutations in the anthrax toxin receptor 2 gene (ANTRX2). Shieh JT, Swidler P, Martignetti JA, Ramirez MC, Balboni I, Kaplan J, Kennedy J, Abdul-Rahman O, Enns GM, Sandborg C, Slavotinek A, Hoyme HE. Pediatrics. 2006; 118 (5): e1485-92
• The future of rheumatology research: the Childhood Arthritis and Rheumatology Research Alliance. Sandborg C, Curr Probl Pediatr Adolesc Health Care. 2006; 36 (3): 104-9
• History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Research Registry. Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, Dyer A, Curdy DM, Vogler L, Reed A, Cawkwell G, Zemel L, Sandborg C, Rivas-Chacon R, Hom C, Ilowite N, Gedalia A, Gitlin J, Borzy M. Arthritis Rheum. 2005; 53 (2): 166-72
• The first step: DNAR outside the hospital and the role of pediatric medical care providers. Collier J, Sandborg C. Am J Bioeth. 2005; 5 (1): 85-6; author reply W19-21
• Adolescent rheumatology transitional care: steps to bringing health policy into practice. Chira P, Sandborg C. Rheumatology (Oxford). 2004; 43 (6): 687-9
• Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus. Schanberg LE, Sandborg C. Curr Rheumatol Rep. 2004; 6 (6): 425-33
• Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection. Hsu D, Sandborg C, Hahn JS. J Child Neurol. 2004; 19 (4): 304-6
• Role of pediatric and internist rheumatologists in treating children with rheumatic diseases. Mayer ML, Sandborg CI, Mellins ED. Pediatrics. 2004; 113 (3 Pt 1): e173-81
• Access to pediatric rheumatology care in the United States. Mayer ML, Mellins ED, Sandborg CI. Arthritis Rheum. 2003; 49 (6): 759-65
• Novel therapies in pediatric rheumatic diseases. Chira P, Sandborg CI. Curr Opin Pediatr. 2003; 15 (6): 579-85
• Expression of autoimmunity in the transition from childhood to adulthood: role of cytokines and gender. Sandborg C, J Adolesc Health. 2002; 30 (4 Suppl): 76-80
• Magnetic resonance imaging in the diagnosis and follow up of Takayasu's arteritis in children. Aluquin VP, Albano SA, Chan F, Sandborg C, Pitlick PT. Ann Rheum Dis. 2002; 61 (6): 526-9
• Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Olson JA, Olson DM, Sandborg C, Alexander S, Buckingham B. Pediatrics. 2002; 109 (3): E50
• Development of systemic lupus erythematosus following autologous bone marrow transplant for acute lymphocytic leukemia. Steinbach WJ, Sandborg CI. J Rheumatol. 2001; 28 (6): 1467-8
• Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. Lee T, von Scheven E, Sandborg C. Curr Opin Rheumatol. 2001; 13 (5): 415-21
• A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus. Buckingham BA, Sandborg CI. Clin Immunol. 2000; 96 (2): 86-90
• Position statement of the American College of Rheumatology regarding referral of children and adolescents to pediatric rheumatologists. Executive Committee of the American College of Rheumatology Pediatric Section. Sandborg CI, Wallace CA. Arthritis Care Res. 1999; 12 (1): 48-51
• Childhood systemic lupus erythematosus and neonatal lupus syndrome. Sandborg CI, Curr Opin Rheumatol. 1998; 10 (5): 481-7
• Progressive multifocal leukoencephalopathy in a 15-year-old boy with scleroderma and secondary amyloidosis. Hahn JS, Harris BT, Gutierrez K, Sandborg C. Pediatrics. 1998; 102 (6): 1475-9
• Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. Berman MA, Sandborg CI, Wang Z, Imfeld KL, Zaldivar F, Dadufalza V, Buckingham BA. J Immunol. 1996; 157 (10): 4690-6
• IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta. Sandborg CI, Imfeld KL, Zaldivar F, Wang Z, Buckingham BA, Berman MA. J Immunol. 1995; 155 (11): 5206-12
• HIV type 1 induction of interleukin 1 and 6 production by human thymic cells. Sandborg CI, Imfeld KL, Zaldivar F, Berman MA. AIDS Res Hum Retroviruses. 1994; 10 (10): 1221-9
• HIV-1 infection of macrophages promotes long-term survival and sustained release of interleukins 1 alpha and 6. Berman MA, Zaldivar F, Imfeld KL, Kenney JS, Sandborg CI. AIDS Res Hum Retroviruses. 1994; 10 (5): 529-39
• A naturally occurring 6-9-kilodalton interleukin-1 (IL-1) inhibitor prevents IL-1-mediated islet cytotoxicity but not IL-1-mediated suppression of insulin secretion. Kawahara DJ, Everts M, Buckingham B, Sandborg C, Berman M. J Immunother (1991). 1991; 10 (3): 182-8
• Interleukin-1 and a 7-kDa T-cell inhibitory monokine reflect disease activity in infection with HIV-1. Sandborg CI, Berman MA, Imfeld KL, Cesario TC, Zaldivar F. J Acquir Immune Defic Syndr. 1990; 3 (12): 1148-54
• Modulation of IL-1 alpha, IL-1 beta, and 25K Mr non-IL-1 activity released by human mononuclear cells. Sandborg CI, Berman MA, Imfeld KL, Zaldivar F, Masada MP, Kenney JS. J Leukoc Biol. 1989; 46 (5): 417-27
• Changes in circulating monocytes in patients with progressive systemic sclerosis. Andrews BS, Friou GJ, Berman MA, Sandborg CI, Mirick GR, Cesario TC. J Rheumatol. 1987; 14 (5): 930-5
• Interleukin 1 inhibitor masks high interleukin 1 production in acquired immunodeficiency syndrome (AIDS). Berman MA, Sandborg CI, Calabia BS, Andrews BS, Friou GJ. Clin Immunol Immunopathol. 1987; 42 (1): 133-40
• Increased production of an interleukin 1 (IL-1) inhibitor with fibroblast stimulating activity by mononuclear cells from patients with scleroderma. Sandborg CI, Berman MA, Andrews BS, Mirick GR, Friou GJ. Clin Exp Immunol. 1986; 66 (2): 312-9
• Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis. Andrews BS, Friou GJ, Barr RJ, Mirick GR, Berman M, Sandborg C, Ross PA. J Rheumatol. 1986; 13 (2): 341-8
• Skin, joint, and pulmonary changes in type I diabetes mellitus. Buckingham B, Perejda AJ, Sandborg C, Kershnar AK, Uitto J. Am J Dis Child. 1986; 140 (5): 420-3
• Studies of an interleukin 1 inhibitor: characterization and clinical significance. Berman MA, Sandborg CI, Calabia BS, Andrews BS, Friou GJ. Clin Exp Immunol. 1986; 64 (1): 136-45
• Interleukin-1 production by mononuclear cells from patients with scleroderma. Sandborg CI, Berman MA, Andrews BS, Friou GJ. Clin Exp Immunol. 1985; 60 (2): 294-302
• Scleroderma-like changes in insulin-dependent diabetes mellitus: clinical and biochemical studies. Buckingham BA, Uitto J, Sandborg C, Keens T, Roe T, Costin G, Kaufman F, Bernstein B, Landing B, Castellano A. Diabetes Care. 1984 Mar-Apr; 7 (2): 163-9
• Neonatal hypernatremia associated with elevated sodium concentration of breast milk. Anand SK, Sandborg C, Robinson RG, Lieberman E. J Pediatr. 1980; 96 (1): 66-8
• Competition for host essential and nonessential fatty acids by Ehrlich ascites carcinoma in mice. Baker N, Sandborg C, Morris D, Ookhtens M. Cancer Res. 1977; 37 (7 Pt 1): 2218-25
• Blood sampling techniques for studying rapidly turning over metabolic fuels in mice. Baker N, Morris D, Sandborg C. Lipids. 1976; 11 (11): 818-20